6533b7d7fe1ef96bd1268de2

RESEARCH PRODUCT

Thrombolysis plus heparin versus heparin alone in the acute phases of unstable angina: preliminary findings

Giorgio MaringhiniVincenzo BuccaCarlo FernandezPietro Di PasqualeRosa RizzoFernanda PipitoneSalvatore Paterna

subject

PharmacologyFirst episodemedicine.medical_specialtyRandomizationT-plasminogen activatorbusiness.industrymedicine.drug_classUnstable anginamedicine.medical_treatmentAnticoagulantHeparinThrombolysisChest painmedicine.diseaseSurgeryAnesthesiamedicinePharmacology (medical)medicine.symptombusinessmedicine.drug

description

Abstract Several studies have shown conflicting effects of thrombolysis in patients with unstable angina. In these trials the time between presentation with chest pain and randomization was long (12 hours to 3 days). This study compared thrombolysis and heparin with heparin-alone treatment in patients in the acute phase of unstable angina. One hundred fifty-three consecutive patients hospitalized with chest pain at rest (first episode) lasting >5 minutes but P = 0.013). Data suggest that thrombolysis plus heparin produces faster clinical stabilization than heparin alone in patients treated during the acute phase of unstable angina.

https://doi.org/10.1016/0011-393x(95)85121-6